Commentary on: "Focal cryosurgical ablation of the prostate: A single institute's perspective"

Abstract

The morbidity of whole gland treatment for prostate cancer is significant. Given the low risk of prostate cancer specific mortality for most men diagnosed with prostate cancer, alternative therapies such as sub-total or hemi-ablation of the prostate and focal ablation of prostate tumors are being investigated. The developing role of imaging for prostate tumors will dramatically change and likely improve the treatment morbidity for low risk prostate tumors. Commentary on:. © 2013 Metwalli and Pinto; licensee BioMed Central Ltd.